Related Experiment Video
Updated: Feb 3, 2026

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Is NREM-predominant obstructive sleep apnea syndrome a different clinical entity?
Abstract:
Background/aim: This study aimed to evaluate whether NREM-predominant obstructive sleep apnea syndrome (OSAS) patients (NREM AHI < REM AHI) have distinct clinical and polysomnographic features compared to REM-predominant OSAS patients (REM AHI > NREM AHI). Materials and methods: A total of 342 patients (93 females and 249 males) who were admitted to the Sleep Disorders Unit at the Gazi University Faculty of Medicine and underwent polysomnography between January 2011 and April 2016 were retrospectively reviewed. Patient data, symptoms related to OSAS, Epworth Sleepiness Scale (ESS) scores, and polysomnographic findings were recorded. The patients were divided into two groups according to the apnea-hypopnea index (AHI) as patients with NREM-predominant OSAS and patients with REM-predominant OSAS. Results: The total AHI in the NREM-predominant group was significantly higher than in the REM-predominant group (P < 0.001). The patients with severe OSAS constituted the majority in both groups, and the rate of patients with severe OSAS was significantly higher in the NREM-predominant group than in the REM-predominant group (P < 0.001). Arousal index and sleep time spent under 90% SaO2 was higher in the NREM-predominant group (P = 0.005, P = 0.001), whereas nocturnal mean and minimum O2 saturation values were lower in the NREM-predominant group compared to patients with REM-predominant OSAS (P < 0.001, P = 0.013). In evaluating systemic disorders, the prevalence of coronary artery disease was significantly higher in the NREM-predominant OSAS group (P < 0.001). Conclusion: Our results showed that patients with NREM-predominant OSAS had a more severe course than patients with REMpredominant OSAS. However, we found no significant difference in sleep-specific symptoms, suggesting that the two groups represented distinct entities.
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS

